Projected Public Health Impact of a Universal Rotavirus Vaccination Program in France

被引:0
|
作者
Oluwaseun, Sharomi [1 ]
Cagnan, Lauren [2 ]
Xausa, Ilaria [3 ]
Nachbar, Robert B. [3 ]
Bachelot, Laurie Levy [4 ]
Chen, Yao-Hsuan [5 ]
Carias, Cristina [6 ]
机构
[1] Merck & Co Inc, BARDS HEDS Dept, Rahway, NJ USA
[2] MSD France, Market Access Dept, Courbevoie, France
[3] Wolfram Res Inc, Wolfram Solut Dept, Champaign, IL USA
[4] MSD France, CORE Reg, Courbevoie, France
[5] MSD UK Ltd, BARDS HEDS, London, England
[6] Merck & Co Inc, CORE PL, Rahway, NJ USA
关键词
rotavirus vaccines; vaccination; France; COST-EFFECTIVENESS; GASTROENTERITIS; CHILDREN; BURDEN; HOSPITALIZATIONS; INFECTIONS; PROTECTION; MORBIDITY; EFFICACY; DISEASES;
D O I
10.1097/INF.0000000000004448
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective:In June 2022, French health authorities issued a universal recommendation for routine administration and reimbursement of rotavirus vaccines in infants. Given this recent recommendation by French health authorities, we sought to understand the public health impact of a universal rotavirus vaccination strategy compared with no vaccination.Materials and Methods:A deterministic, age-structured, nonlinear dynamic transmission model, accounting for herd immunity, was developed. We considered 3 vaccination coverage scenarios: high (95%), medium (75%) and low (55%). Model parameter values were based on published modeling and epidemiological literature. Model outcomes included rotavirus gastroenteritis (RVGE) cases and healthcare resource utilization due to RVGE (hospitalizations, general practitioner or emergency department visits), as well as the number needed to vaccinate to prevent 1 RVGE case (mild or severe) and 1 RVGE-related hospitalization. Model calibration and analyses were conducted using Mathematica 11.3.Results:Over 5 years following implementation, RVGE cases for children under 5 years are estimated to be reduced by 84% under a high vaccination coverage scenario, by 72% under a medium vaccination coverage scenario and by 47% under a low vaccination coverage scenario. Across all scenarios, the number needed to vaccinate to avert 1 RVGE case and hospitalization varied between 1.86-2.04 and 24.15-27.44, respectively.Conclusions:Rotavirus vaccination with high vaccination coverage in France is expected to substantially reduce the number of RVGE cases and associated healthcare resource utilization.
引用
收藏
页码:902 / 908
页数:7
相关论文
共 50 条
  • [21] Rotavirus Disease Burden and Impact and Cost-Effectiveness of a Rotavirus Vaccination Program in Kenya
    Tate, Jacqueline E.
    Rheingans, Richard D.
    O'Reilly, Ciara E.
    Obonyo, Benson
    Burton, Deron C.
    Tornheim, Jeffrey A.
    Adazu, Kubaje
    Jaron, Peter
    Ochieng, Benjamin
    Kerin, Tara
    Calhoun, Lisa
    Hamel, Mary
    Laserson, Kayla
    Breiman, Robert F.
    Feikin, Daniel R.
    Mintz, Eric D.
    Widdowson, Marc-Alain
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2009, 200 : S76 - S84
  • [22] Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China
    Liu, Na
    Yen, Catherine
    Fang, Zhao-yin
    Tate, Jacqueline E.
    Jiang, Baoming
    Parashar, Umesh D.
    Zeng, Guang
    Duan, Zhao-jun
    [J]. VACCINE, 2012, 30 (48) : 6940 - 6945
  • [23] WHO calls for universal rotavirus vaccination
    不详
    [J]. EXPERT REVIEW OF VACCINES, 2009, 8 (08) : 973 - 973
  • [24] Rotavirus genomics. Public health impact
    Lopez, Susana
    Arias, Carlos F.
    [J]. SALUD PUBLICA DE MEXICO, 2020, 62 (01): : 36 - 41
  • [25] Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France
    Majed, Laureen
    Bresse, Xavier
    El Mouaddin, Nadia
    Schmidt, Aurelie
    Daniels, Vincent J.
    Pavelyev, Andrew
    Levy-Bachelot, Laurie
    Elbasha, Elamin
    [J]. VACCINE, 2021, 39 (02) : 438 - 446
  • [26] Projected Impact of the New Rotavirus Vaccination Program on Hospitalizations for Gastroenteritis and Rotavirus Disease among US Children <5 Years of Age during 2006-2015
    Curns, Aaron T.
    Coffin, Fanny
    Glasser, John W.
    Glass, Roger I.
    Parashar, Umesh D.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2009, 200 : S49 - S56
  • [27] The projected public health and economic impact of vitamin D fortified dairy products for fracture prevention in France
    Hiligsmann, Mickael
    Reginster, Jean-Yves
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2018, 18 (02) : 191 - 195
  • [28] PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS ANALYSIS OF UNIVERSAL VARICELLA VACCINATION IN THE UNITED KINGDOM
    Jamet, N.
    George, M.
    Shah, H. A.
    Oliyide, A.
    Zerda, I
    Cristeau, O.
    Casabona, G.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S221 - S222
  • [29] DECIDING ON UNIVERSAL ROTAVIRUS VACCINATION IN THE NETHERLANDS AGAIN
    Dvortsin, E.
    Zeevat, F.
    Novak, A.
    Postma, M. J.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A798 - A798
  • [30] Rotavirus Infection in the Auckland Region After the Implementation of Universal Infant Rotavirus Vaccination: Impact on Hospitalizations and Laboratory Implications
    McAuliffe, Gary N.
    Taylor, Susan L.
    Drinkovic, Dragana
    Roberts, Sally A.
    Wilson, Elizabeth M.
    Best, Emma J.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2018, 37 (01) : E1 - E5